Tion, UV, in the Clearance Calculation, Ie, IV/P = Ously by the Infusion Technique, and on the Appli

Tion, UV, in the Clearance Calculation, Ie, IV/P = Ously by the Infusion Technique, and on the Appli

COMPARISON OF THE CONSTANT INFUSION AND URINE COLLECTION TECHNIQUES FOR THE MEASUREMENT OF RENAL FUNCTION 1 BY EUGENE Y. BERGER, SAUL J. FARBER, AND DAVID P. EARLE, JR. WITH THE TECHNICAL ASSISTANCE OF ROSALYN JACKENTHAL (From the Third [New York University] Research Service, Goldwater Memorial Hospital, and the Department of Medicine, New York University College of Medicine, New York City) (Received for publication May 8, 1948) For any exogenous substance which is neither bladder rinses with water and air. The maximum rate metabolized, stored nor excreted otherwise than in of excretion of PAH by the tubules (TmPaH) was also measured in some of the experiments (3). Three or the urine, the rate of excretion must be equal to the more serial urine collection periods of 15 to 30 minutes rate of infusion under conditions where its plasma each were measured. level and volume of distribution are constant. Priming injections of inulin and PAH were given This steady state, as indicated by a constant plasma intravenously in amounts calculated to achieve plasma level, will be designated infusion equilibrium. levels of 5 to 20 and 2 to 3 mg. per cent respectively. The approximate volume of distribution for an average A simplified method for the measurement of normal subject was taken as 15 liters for inulin and 20 glomerular filtration rate and the effective renal liters for PAH. Priming injections of 2 grams of inulin plasma flow based upon the above principle has and 0.8 gram sodium p-aminohippurate were frequently been described elsewhere (1). In the application used and generally resulted in plasma levels of 10 to 15 of the principle, the rate of infusion, IV (where I and 2.5 to 3.0 mg. per cent respectively. Priming doses were modified for persons of unusual size, and were is the concentration in mg. per ml. of infusion fluid greatly increased in the presence of edema. and V is the volume of fluid injected in ml. per The sustaining infusions were delivered by a pump at minute), can be substituted for the rate of excre- a rate calculated, on the basis of estimated renal function, tion, UV, in the clearance calculation, i.e., IV/P = to maintain the desired plasma concentrations. For ex- ample, if the estimated filtration rate was 100 ml. per UV/P. The procedure, therefore, obviates the minute and if the plasma inulin concentration desired, necessity of bladder catheterization and the errors and presumably achieved by the priming injection, was 5 inherent in urine collection. mg. per cent then each minute 100 X 0.05 or 5 mg. would The. study presented here embodies further ob- be excreted in the urine. The sustaining infusion, there- servations, obtained under normal and abnormal fore, would deliver 5 mg. of inulin per minute. For Tmpma measurements the desired plasma PAH circumstances, on the correlation of inulin and level was roughly calculated for a load/Tm ratio of 2 p-aminohippuric acid clearances as measured by from the equation: urine collections with those measured simultane- Plasma PAH level X renal plasma flow (measured ously by the infusion technique, and on the appli- or estimated) cation of the infusion technique to the measure- Anticipated TmPAH ment of p-aminohippuric acid Tm. The priming PAH dose was calculated from the desired plasma PAH level and a volume of distribution of 20 EXPERIMENTAL PROCEDURE liters for the individual of average size. The estimated plasma PAH level was substituted in the Glomerular filtration rate and renal plasma flow were formula (3): Anticipated TmPAH =UV - 0.83 CINPPAH, estimated from the clearances (2, 3) of inulin and p- aminohippurate (PAH) 2 by the usual urine collection where CIN represents the anticipated inulin clearance. technique involving the use of a multi-eyed catheter and The equation was solved for the term UV which repre- sents the amount of PAH excreted in the urine per unit 1 This investigation was supported by a grant from the of time and, therefore, the amount which must also be Life Insurance Medical Research Fund. delivered by the sustaining infusion. 2The authors are indebted to the Medical Research The infusion pump used in the early experiments con- Division of Sharp and Dohme, Inc., of Glenolden, Pa., sisted of a worm-drive rod powered by a constant speed for generous supplies of sodium-p-aminohippurate in motor that pushed on the plunger of a 50- or 100-ml. ampules. syringe. The rate of delivery with the 50-ml. syringe 710 CONSTANT INFUSION AND URINE COLLECTION TECHNIQUES 711 was approximately 0.12 ml. per minute, and approxi- destruction during the procedure, it was impossible to mately 0.25 ml. per minute with a 100-ml. syringe. This hydrolyze the infusion fluids and the plasma filtrates and pump was inconvenient for use in experiments lasting urines so that they were precisely comparable. more than three hours since the syringe had to be refilled At the high plasma PAH levels maintained during the and the rate of delivery of fluid could be varied only by TmPAH measurements, the fraction of the compound con- changing to a larger or smaller syringe. jugated was so small, and could not be detected, and Subsequently a Bayliss infusion pump was adopted, hydrolysis was, therefore, unnecessary (3). consisting of a series of rollers which rotated in ferris wheel fashion compressing a short length of the infusion RESULTS tubing. The pump was powered by a constant speed electric motor. The rate of revolution of the wheel was Glomerular filtration rate and renal plasma flow regulated by a variable speed transmission. Some surg- as measured by the infusion pump technique ing occurred with this pump, but over periods greater were compared with simultaneous measurements than one minute the rate of delivery was constant. De- livery rates with this pump using ordinary intravenous by the usual methods involving serial urine collec- rubber tubing could be varied at will between 1 and 3 tions. Unless stated otherwise, all clearance data ml. per minute. recorded in the table and figures represent the Generally, infusion equilibrium, as indicated by constant average of three or more consecutive periods. plasma inulin and PAH concentrations, was achieved at The clearance values are not corrected for surface the end of one hour in normal subjects. The period al- lowed for attainment of equilibrium was frequently ex- area. tended to one and one-half hours, and even then there For present purposes it was assumed that infu- were a few instances where the plasma levels were still sion equilibrium existed whenever there was less changing during subsequent experimental periods. than a 6 per cent variation between the serial Throughout this work all infusion technique clearances plasma inulin and PAH concentrations. The vari- are based on plasma inulin and PAH levels obtained at the approximate mid-points of the standard urine col- ations in plasma level were within the limits of lection periods. error of the methods of analysis in the majority of experiments. CHEMICAL METHODS The average urine/infusion clearance ratio for = Inulin was determined by Harrison's modification (4) inulin was 1.00 (a 0.054) in 45 experiments in of the calorimetric method of Alving, Rubin and Miller 26 subjects with normal kidneys and ten with renal (5). Protein-free filtrates were obtained by the Somogyi disease. These data are summarized in Figure 1.8 zinc precipitation (6). For inulin analysis, infusion The glomerular filtration rates in these subjects fluids, urines and plasmas were all treated with yeast so ranged from 168 to 14 ml. per minute. In general, that all analyses would be comparable. Plasma, obtained before the injection of inulin, was used as a blank. there was less variation among the individual PAH was measured by the Bratton-Marshall reaction clearances in any given experiment as measured (7). Since PAH is conjugated by man it is necessary by the infusion method than among the clearances in the infusion technique to determine "total" PAH after as measured by urine collections. For example, hydrolysis. Proteins were precipitated with 3 ml. of 15 comparisons between the two techniques were per cent trichloracetic acid per 1 ml. of plasma and 10 ml. of water. Conjugated PAH was hydrolyzed by made during ten consecutive periods in a single heating 10 ml. of the filtrate with 1 ml. of 1.1 N hydro- experiment. The range in filtration rates meas- chloric acid for one hour in a boiling water bath. One ured by urine collection was 122 to 139 ml. per ml. N hydrochloric acid was added to 5 ml. of the hydro- minute, but only 124 to 130 by the infusion tech- lyzed filtrate in a colorimeter tube before addition of the Bratton-Marshall reagents. Plasma blanks were rou- nique. tinely done for each experiment. The average urine/infusion clearance ratio for A small amount of PAH was destroyed when sub- PAH in 26 experiments in 23 of the same sub- jected to the above hydrolysis procedure, the amount in- jects was 0.975 (0 = 0.049). These data are creasing with time. On the other hand, hydrolysis of shown in Figure 2.3 It is likely that the slightly acetyl-PAH increased with duration of heating. The conditions outlined above were chosen as those which low urine/infusion ratio is the result of some loss permit the greatest degree of hydrolysis with the least 3 For the sake of clear presentation, one datum that destruction of PAH. When known amounts of acetyl- fell below 25 ml. per minute was omitted from Figure 1, PAH were subjected to the procedure described above, three data that fell below 300 ml.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    7 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us